In a significant Texas probate ruling, an appeals court has affirmed summary judgment in favour of executors, finding the plaintiffs’ claims were barred by the statute of limitations. The case, Conover v.
Artificial intelligence is rapidly reshaping the legal industry, and the transformation is no longer limited to the largest and most resource-rich law firms. AI-native law firms, built from the ground up around
MoreLondon stocks closed sharply higher on Thursday, driven by falling bond yields and a declining oil price as markets absorbed the Bank of England’s latest rate decision. The FTSE 100 index ended
MorePaymentus Holdings (PAY) has seen its earnings outlook revised upward, prompting fresh debate about what the development means for existing and prospective shareholders. An improved earnings forecast is generally considered a positive
MoreThe Saudi Pro League is giving players a new way to profit from the competition, with a revenue-sharing initiative tied to social media promotion of live match streams. The scheme, called “Share
MoreThe Court of Appeal has issued a significant ruling in Geeks Ltd v Watts [2026] EWCA Civ 889, surprising many employment law practitioners across the UK. The decision examined whether training repayment
MoreThe Texas Senate race has found an unlikely arena for its sharpest political commentary, with a comedy podcast cutting through where traditional media has hesitated. Ron White, the scotch-in-hand veteran of the
MoreAmerican Savings Bank, trading under the ticker ASB on the New York Stock Exchange, made a strong first impression as shares jumped more than 6% on its trading debut. The bank’s opening
MorePets at Home Group (PETS), one of the UK’s largest specialist pet care retailers, has seen its share price fall by 59%, raising questions about whether the stock now offers value for
MoreAutomated cell therapy manufacturing specialist Cellares is joining forces with Taiwanese biotech GenomeFrontier Therapeutics to advance virus-free CAR-T production. The partnership will assess whether GenomeFrontier’s virus-free manufacturing process is compatible with Cellares’
MoreGrowth equity has established itself as one of the most resilient corners of private markets, drawing significant capital even as other strategies struggle with expensive debt and cautious lenders. Funds focused on
More
